These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3336397)

  • 21. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
    Greene MH; Young RC; Merrill JM; DeVita VT
    Cancer Res; 1983 Apr; 43(4):1891-8. PubMed ID: 6572558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of second tumors in patients with Hodgkin's disease (review of the literature and personal data)].
    Kanaev SV; Kholin AV; Gershanovich ML; Malinin AP
    Vopr Onkol; 1987; 33(5):11-8. PubMed ID: 3590664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT
    N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
    Lavey RS; Eby NL; Prosnitz LR
    Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second cancers after radiotherapy for Hodgkin's disease.
    N Engl J Med; 1988 Jul; 319(4):244-6. PubMed ID: 3393177
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone sarcomas linked to radiotherapy and chemotherapy in children.
    Tucker MA; D'Angio GJ; Boice JD; Strong LC; Li FP; Stovall M; Stone BJ; Green DM; Lombardi F; Newton W
    N Engl J Med; 1987 Sep; 317(10):588-93. PubMed ID: 3475572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.
    Pedersen-Bjergaard J; Ersbøll J; Hansen VL; Sørensen BL; Christoffersen K; Hou-Jensen K; Nissen NI; Knudsen JB; Hansen MM
    N Engl J Med; 1988 Apr; 318(16):1028-32. PubMed ID: 3352696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
    van Leeuwen FE; Somers R; Taal BG; van Heerde P; Coster B; Dozeman T; Huisman SJ; Hart AA
    J Clin Oncol; 1989 Aug; 7(8):1046-58. PubMed ID: 2754447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of second cancers in managing Hodgkins disease: the 20-year Leiden experience.
    Sont JK; van Stiphout WA; Noordijk EM; Molenaar J; Zwetsloot-Schonk JH; Willemze R; Vandenbroucke JP
    Ann Hematol; 1992 Nov; 65(5):213-8. PubMed ID: 1457578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second solid malignancies after combined modality therapy for Hodgkin's disease.
    Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
    J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma.
    Daniëls LA; Krol AD; Schaapveld M; Putter H; Jansen PM; Marijt EW; van Leeuwen FE; Creutzberg CL
    Radiother Oncol; 2013 Oct; 109(1):140-5. PubMed ID: 23932152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second cancers following pediatric Hodgkin's disease.
    Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
    J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    N Engl J Med; 1987 Sep; 317(11):707-9. PubMed ID: 3627177
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of new cancers in patients with Hodgkin's disease.
    Arseneau JC; Canellos GP; Johnson R; DeVita VT
    Cancer; 1977 Oct; 40(4 Suppl):1912-6. PubMed ID: 907993
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
    Cadman EC; Capizzi RL; Bertino JR
    Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second malignant lesions after therapy for Hodgkin's disease.
    Schomberg PJ; Evans RG; Banks PM; White WL; O'Connell MJ; Earle JD
    Mayo Clin Proc; 1984 Jul; 59(7):493-7. PubMed ID: 6588280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.